John Klein - Chairman and CEO of Cambridge Therapeutics

John Klein - Founder of Cambridge Therapeutics

A New Jersey executive with nearly three decades of experience in the health care and pharmaceutical industries, John Klein serves as the CEO and chairman of the Board of Managers with Cambridge Therapeutics, which provides novel drug delivery services, physician prescription dispensing, and combination drug therapies. The organization’s founder, John Klein, also served as its CEO for several years.

Previously, Mr. Klein served as the chairman and CEO of Dava Pharmaceutical Company, where he managed contracts across the globe. His earlier experience includes a role as Kindred Healthcare’s lead independent director, NovaDel Pharma’s chairman and director, and Strategic Business & Technology Solutions’ director and chairman. Moreover, he served in a number of leadership roles at Cybear; MIM Corp.; Ivax, NA; Zenith Laboratories, Inc.; Molex Inc.; and Viking Technologies.

A trustee of Hackensack Meridian Health Hospitals, John Klein fulfills similar obligations with the Dwight-Englewood School, of which he is a past president. A recipient of a BS and MBA from Roosevelt University, he has completed additional coursework in business and finance at the University of Southern California, as well as in marketing-related decision-making for CEOs at the Wharton School of the University of Pennsylvania.